| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Addex Therapeutics Ltd.
13D/A
ADXN · 00654J206
|
9.0% |
9/4/2026
Event 9/2/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.